Position history for UBS Group AG's holdings in MAINZ BIOMED N V
UBS Group AG holds 86,576 shares of MYNZ (MAINZ BIOMED N V), worth $41,037 as of 2026-Q1. The position was increased (+59.8% shares).
Current Value
$41,037
Current Shares
86,576
Total Value Change
+$41,037
Total Shares Change
+86,576
Other major holders of MYNZ: Cerity Partners LLC, CITADEL ADVISORS LLC, Virtu Financial LLC, MORGAN STANLEY
Increased |
| 86,576 |
+59.8% |
| $41,037 |
| 0.0% |
| $0.84 |
20 |
| 2025-Q4 | Increased | 54,181 | +674.1% | $60,683 | 0.0% | $1.16 | 23 |
| 2025-Q3 | Decreased | 6,999 | -28.6% | $10,428 | 0.0% | $1.46 | 0 |
| 2025-Q2 | Increased | 9,808 | +413.2% | $13,829 | 0.0% | $1.38 | 20 |
| 2025-Q1 | Decreased | 1,911 | -49.2% | $6,134 | 0.0% | $3.58 | 0 |
| 2024-Q4 | New | 3,762 | - | $16,252 | 0.0% | $4.56 | 28 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $0.40 | 0 |